Rationale and design of the AFFIRM‐AHF trial: a randomised, double‐blind, placebo‐controlled trial comparing the effect of intravenous ferric carboxymaltose on hospitalisations and mortality in iron‐deficient patients admitted for acute heart failure
暂无分享,去创建一个
P. Ponikowski | G. Filippatos | A. Keren | M. Metra | S. Anker | F. Ruschitzka | T. McDonagh | D. Miličić | J. Nicolau | F. Martinez | E. Jankowska | M. Dorobanțu | D. Pascual-Figal | B. Kirwan | H. Kragten | H. Skouri | D. Sim | J. Drożdż | P. Meer | M. Ohlsson | V. Fabien | I. Khintibidze | T. Haboubi | Alexander Parhomenko